Hearing News Watch

SOMERSET, NEW JERSEY — On December 6th, Oticon President Gary Rosenblum and Mariann Cadieu, Executive Director of the Oticon Hearing Foundation, visited Mary’s Place by the Sea—a respite home dedicated to supporting women battling cancer. The facility received a generous donation raised through the dedicated efforts of Demant staff volunteers and sales promotions. During their visit, the team toured the

Hearing loss, a condition affecting millions globally, often extends beyond the obvious symptoms captured by standard audiograms. Up to 10% of patients experiencing hearing difficulties have conditions that remain undiagnosed through conventional clinical tests. Addressing this unmet need, researchers at the University of Pittsburgh have developed a groundbreaking diagnostic tool for detecting hidden hearing pathologies, offering new hope for improved

SEATTLE, WASHINGTON — Sound Pharmaceuticals announced today that its pivotal Phase 3 clinical trial evaluating SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of Meniere’s Disease (STOPMD-3) successfully met its co-primary efficacy endpoints. These results demonstrate significant improvements in hearing loss and speech discrimination. Meniere’s disease (MD) is an inner ear disorder that causes fluctuating hearing loss, tinnitus, and

The European Union of Hearing Aid Acousticians (EUHA) has announced the call for papers for its upcoming Digital EUHA Spring Conference, scheduled to begin on March 28, 2025. The conference, an established event in the hearing care community, attracts both members and non-members, including a significant number of international participants. The event will feature live presentations on the opening day,

A new USC Stem Cell study published in the Proceedings of the National Academy of Sciences (PNAS), reveals the genetic mechanisms that enable fish and lizards to regenerate their hearing after injury. By identifying key gene regulators and DNA control elements, the research offers valuable insights into sensory cell regeneration, paving the way for potential therapeutic strategies to restore hearing

MONTPELLIER, FRANCE – Cilcare, a biotechnology company specializing in auditory sciences, has announced the completion of its €40 million Series A funding round, with €21 million secured in the latest phase. This milestone was achieved with the participation of new investors, including SHIONOGI & CO., LTD., and Sprim Global Investments Pte. Ltd., as well as existing backers such as Sofilaro,

GAINESVILLE, FLORIDA – Neurotone AI, a pioneer in aural rehabilitation and creator of Lace AI Pro, has announced a definitive agreement to acquire Amptify, a leading digital hearing healthcare platform developed at Washington University in St. Louis School of Medicine. The transaction, expected to close by the end of 2024, is subject to customary closing conditions. This acquisition aligns with

CHARLESTON, SOUTH CAROLINA – Dr. Douglas L. Beck, co-host of the Hearing Matters Podcast, has been awarded the prestigious 2024 Golden Lobe Award by the Association of Independent Hearing Healthcare Professionals (AIHHP). This award is granted annually to a distinguished hearing healthcare professional who has made outstanding contributions to the field of audiology. Dr. Beck, renowned for being among the

Case Western Reserve University and Mass Eye and Ear researchers have been awarded a five-year, $3.2 million grant from the National Institute on Deafness and Other Communication Disorders (NIDCD). The study aims to uncover the mechanisms behind acquired hearing loss (AHL) and explore strategies to prevent it. AHL is one of the most prevalent health issues among older adults, according

EDEN PRAIRIE, MINNESOTA – Hall of Fame rockstar Alice Cooper joined Starkey Chief Hearing Health Officer Dave Fabry on the latest episode of Starkey Sound Bites to share his story about hearing loss and combating the stigma of hearing aids. He says, for many professional musicians, hearing loss is an unfortunate reality, but it doesn’t have to be that way. “At this